European Journal of Surgical Oncology
Volume 36, Issue 7 , Pages 617-624 , July 2010

Tailored follow-up for early breast cancer patients: A prognostic index that predicts locoregional recurrence

  • J.G.H. van Nes

      Affiliations

    • Department of Surgery, Leiden University Medical Centre, K6-R, P.O. Box 9600, 2300 RC Leiden, The Netherlands
    • ,
  • H. Putter

      Affiliations

    • Department of Medical Statistics, Leiden University Medical Centre, P.O. Box 9600, 2300 RC Leiden, The Netherlands
    • ,
  • M. van Hezewijk

      Affiliations

    • Department of Radiation Oncology, Leiden University Medical Centre, P.O. Box 9600, 2300 RC Leiden, The Netherlands
    • ,
  • E.T.M. Hille

      Affiliations

    • Datacentre, Leiden University Medical Centre, P.O. Box 9600, 2300 RC Leiden, The Netherlands
    • ,
  • H. Bartelink

      Affiliations

    • Department of Radiation Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    • ,
  • L. Collette

      Affiliations

    • European Organisation of Cancer Research and Treatment, Avenue Mounierlaan 83/11, Brussel 1200, Belgium
    • ,
  • C.J.H. van de Velde

      Affiliations

    • Department of Surgery, Leiden University Medical Centre, K6-R, P.O. Box 9600, 2300 RC Leiden, The Netherlands
    • Corresponding Author InformationCorresponding author. Tel.: +31 71 526 2309; fax: +31 71 526 6750.
    • ,
  • on behalf of the EORTC Breast Cancer Group

      Affiliations

    • European Organisation of Cancer Research and Treatment, Avenue Mounierlaan 83/11, Brussel 1200, Belgium

,Accepted 4 May 2010.

References 

  1. Khatcheressian JL, Wolff AC, Smith TJ, et al. American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting. J Clin Oncol. 2006;24:5091–5097
  2. Loprinzi CL. It is now the age to define the appropriate follow-up of primary breast cancer patients. J Clin Oncol. 1994;12:881–883
  3. Renton JP, Twelves CJ, Yuille FA. Follow-up in women with breast cancer: the patients’ perspective. Breast. 2002;11:257–261
  4. Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin. 2005;55:10–30
  5. Maher EJ. Non-surgical management of early breast cancer in the United Kingdom: follow-up. Clinical Audit Sub-committee of the Faculty of Clinical Oncology, Royal College of Radiologists, and the Joint Council for Clinical Oncology. Clin Oncol (R Coll Radiol). 1995;7:227–231
  6. de Bock GH, Bonnema J, van der Hage JA, et al. Effectiveness of routine visits and routine tests in detecting isolated locoregional recurrences after treatment for early-stage invasive breast cancer: a meta-analysis and systematic review. J Clin Oncol. 2004;22:4010–4018
  7. Rojas MP, Telaro E, Russo A, et al. Follow-up strategies for women treated for early breast cancer. Cochrane Database Syst Rev. 2005;CD001768
  8. The GIVIO Investigators . Impact of follow-up testing on survival and health-related quality of life in breast cancer patients. A multicenter randomized controlled trial. The GIVIO Investigators. J Am Med Assoc. 1994;271:1587–1592
  9. Rosselli Del Turco M, Palli D, Cariddi A, et al. Intensive diagnostic follow-up after treatment of primary breast cancer. A randomized trial. National Research Council Project on Breast Cancer follow-up. J Am Med Assoc. 1994;271:1593–1597
  10. van Dongen JA, Voogd AC, Fentiman IS, et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10,801 trial. J Natl Cancer Inst. 2000;92:1143–1150
  11. Haybittle JL, Blamey RW, Elston CW, et al. A prognostic index in primary breast cancer. Br J Cancer. 1982;45:361–366
  12. Nuyten DSA, Kreike B, Hart AAM, et al. Predicting a local recurrence after breast-conserving therapy by gene expression profiling. Breast Cancer Res. 2006;8:R62
  13. Clahsen PC, van de Velde CJH, Julien JP, et al. Improved local control and disease-free survival after perioperative chemotherapy for early-stage breast cancer. A European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group Study. J Clin Oncol. 1996;14:745–753
  14. van Nes JGH, Putter H, Julien JP, et al. Preoperative chemotherapy is safe in early breast cancer, even after 10 years of follow-up; clinical and translational results from the EORTC trial 10,902. Breast Cancer Res Treat. 2009;115:101–113
  15. Bartelink H, Horiot JC, Poortmans PM, et al. Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22,881–10,882 trial. J Clin Oncol. 2007;25:3259–3265
  16. Sauerbrei W, Schumacher M. A bootstrap resampling procedure for model building: application to the Cox regression model. Stat Med. 1992;11:2093–2109
  17. Verweij PJ, van Houwelingen HC. Cross-validation in survival analysis. Stat Med. 1993;12:2305–2314
  18. Putter H, Fiocco M, Geskus RB. Tutorial in biostatistics: competing risks and multi-state models. Stat Med. 2007;26:2389–2430
  19. Harrell FE, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15:361–387
  20. Yan G, Greene T. Investigating the effects of ties on measures of concordance. Stat Med. 2008;27:4190–4206
  21. Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347:1227–1232
  22. Overgaard M, Jensen MB, Overgaard J, et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet. 1999;353:1641–1648
  23. Elkhuizen PHM, van de Vijver MJ, Hermans J, et al. Local recurrence after breast-conserving therapy for invasive breast cancer: high incidence in young patients and association with poor survival. Int J Radiat Oncol Biol Phys. 1998;40:859–867
  24. Jobsen JJ, van der PJ, Ong F, et al. The value of a positive margin for invasive carcinoma in breast-conservative treatment in relation to local recurrence is limited to young women only. Int J Radiat Oncol Biol Phys. 2003;57:724–731
  25. Clark RM, McCulloch PB, Levine MN, et al. Randomized clinical trial to assess the effectiveness of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer. J Natl Cancer Inst. 1992;84:683–689
  26. Mirza NQ, Vlastos G, Meric F, et al. Predictors of locoregional recurrence among patients with early-stage breast cancer treated with breast-conserving therapy. Ann Surg Oncol. 2002;9:256–265
  27. Dixon JM, Montgomery D. Follow-up after breast cancer. BMJ. 2008;336:107–108
  28. Donnelly PK, Hiller L, Dunn JA. National randomised controlled trial is needed. BMJ. 2008;336:461–462
  29. Montgomery DA, Krupa K, Jack WJ, et al. Changing pattern of the detection of locoregional relapse in breast cancer: the Edinburgh experience. Br J Cancer. 2007;96:1802–1807

☆ Partly presented as poster presentation at the•13th Congress of the European Society of Surgical Oncology, 2006, Venice, Italy (best poster prize).•29th San Antonio Breast Cancer Symposium, 2006, San Antonio, Texas.

PII: S0748-7983(10)00118-6

doi: 10.1016/j.ejso.2010.05.010

European Journal of Surgical Oncology
Volume 36, Issue 7 , Pages 617-624 , July 2010

Article Tools

* Image Usage & Resolution